Switching chemotherapy in adult osteosarcoma patients with poor necrosis rates post neoadjuvant methotrexate, cisplatin, and doxorubicin (MAP).
Grainne O'Kane
No relevant relationships to disclose
Karen Anne Cadoo
No relevant relationships to disclose
Elaine Walsh
No relevant relationships to disclose
Conor O'Keane
No relevant relationships to disclose
Gary O'Toole
No relevant relationships to disclose
Sean Dudney
No relevant relationships to disclose
Desmond Carney
No relevant relationships to disclose